Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Nasus Pharma Ltd. (NSRX) vs Sanofi (SNY)

Nasus Pharma Ltd. and Sanofi are both Drug Manufacturers General companies. Sanofi is the larger, with a market value of $97.4B against $40.8M — 2391.2× the size. Across the 9 metrics below, Sanofi leads on 6 and Nasus Pharma Ltd. on 3.

Valuation

Metric NSRX SNY Drug Manufacturers General median
P/E — 21.52 24.72
P/S — 1.73 3.35
P/B n/m 1.22 5.00
Price to free cash flow n/m 6.77 17.68
EV/EBITDA n/m 11.19 13.91
EV/Sales n/m 2.04 3.95
Earnings yield — 4.65% 2.92%
Free cash flow yield 0.00% 14.78% 4.42%

Profitability

Metric NSRX SNY Drug Manufacturers General median
Gross margin — 72.78% 72.77%
Operating margin — 18.24% 18.90%
Net margin — 8.22% 8.27%
Free cash flow margin 0.00% 25.53% 17.25%
Return on equity 0.00% 5.87% 6.97%
Return on assets 0.00% 3.21% 2.76%
Return on invested capital 0.00% 6.58% 6.30%

Growth

Metric NSRX SNY Drug Manufacturers General median
Revenue growth (TTM) — 21.30% 6.79%
EPS growth (last fiscal year) (231.82%) 45.97% —
Revenue growth, 5-year CAGR — 4.37% 3.98%
Net income growth, 5-year CAGR — (8.87%) 0.42%

Health

Metric NSRX SNY Drug Manufacturers General median
Debt to equity 0.00 0.31 0.63
Current ratio 8.77 0.99 1.32
Net debt to EBITDA 0.26 0.76 1.15

Dividend

Metric NSRX SNY Drug Manufacturers General median
Dividend yield — 4.40% 3.57%
Payout ratio — 0.52 0.53

Size

Metric NSRX SNY Drug Manufacturers General median
Market cap 40.75m 97.44b 125.91b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack